Celltrion Will Market Subcutaneous Remsima Directly After EU Nod

 
• By David Wallace and Jung Won Shin
EMA
The EMA’s CHMP has endorsed Celltrion’s subcutaneous infliximab • Source: Shutterstock

More from Strategy

More from Business